Quantitative Measurement of Glycosylated ⍺-Dystroglycan as a Biomarker for Disease Severity in Limb-Girdle Muscular Dystrophy Type 2I/R9

Neurology: Genetics · Published 2026-04-01 · DOI 10.1212/nxg.0000000000200370

Free full text

Authors being retrieved — see the publisher record. https://doi.org/10.1212/nxg.0000000000200370

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Related articles

• Autosomal Dominant FTH1 Variant Causing Pontocerebellar Hypoplasia and Late-Onset Neuroferritinopathy · Neurology: Genetics · 2026 · Same journal
• DNAJC12 Disease · Neurology: Genetics · 2025 · Same journal
• Toward Trial Readiness in Congenital Myotonic Dystrophy · Neurology: Genetics · 2026 · Same journal
• Precision Diagnosis of Wilson Disease Using a MultiGene Panel · Neurology: Genetics · 2026 · Same journal
• The KCNT1 -Related Epilepsy Study · Neurology: Genetics · 2026 · Same journal
• Plasma isomiRs as Candidate Biomarkers for Amyotrophic Lateral Sclerosis · Neurology: Genetics · 2026 · Same journal
• Preparing Amyotrophic Lateral Sclerosis Clinics to Provide Longitudinal Care for Individuals Carrying ALS Risk Variants · Neurology: Genetics · 2026 · Same journal
• The Association Between APOE Genotype, Race, and Dementia · Neurology: Genetics · 2026 · Same journal
• Augmenting Diagnostic Yield From Genomic Sequencing · Neurology: Genetics · 2026 · Same journal
• Whole-Body Skeletal Muscle MRI Patterns in Female Dystrophinopathy Carriers · Neurology: Genetics · 2026 · Same journal